RhumbLine Advisers’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q2 | – | Sell |
-16,074
| Closed | – | – | 3082 |
|
2019
Q1 | $0 | Sell |
16,074
-302,717
| -95% | – | ﹤0.01% | 2975 |
|
2018
Q4 | $36K | Buy |
318,791
+97,448
| +44% | +$11K | ﹤0.01% | 2962 |
|
2018
Q3 | $376K | Sell |
221,343
-16,175
| -7% | -$27.5K | ﹤0.01% | 2393 |
|
2018
Q2 | $413K | Buy |
237,518
+14,845
| +7% | +$25.8K | ﹤0.01% | 2388 |
|
2018
Q1 | $407K | Buy |
222,673
+5,080
| +2% | +$9.29K | ﹤0.01% | 2293 |
|
2017
Q4 | $485K | Sell |
217,593
-41,815
| -16% | -$93.2K | ﹤0.01% | 2244 |
|
2017
Q3 | $752K | Buy |
259,408
+3,490
| +1% | +$10.1K | ﹤0.01% | 2123 |
|
2017
Q2 | $1.14M | Buy |
255,918
+34,942
| +16% | +$156K | ﹤0.01% | 1882 |
|
2017
Q1 | $1.03M | Buy |
220,976
+20,900
| +10% | +$97.4K | ﹤0.01% | 1892 |
|
2016
Q4 | $1.22M | Buy |
200,076
+17,847
| +10% | +$109K | ﹤0.01% | 1748 |
|
2016
Q3 | $1M | Buy |
182,229
+15,800
| +9% | +$87.1K | ﹤0.01% | 1798 |
|
2016
Q2 | $632K | Buy |
166,429
+69,265
| +71% | +$263K | ﹤0.01% | 2049 |
|
2016
Q1 | $268K | Buy |
97,164
+1,290
| +1% | +$3.56K | ﹤0.01% | 2589 |
|
2015
Q4 | $544K | Buy |
95,874
+7,005
| +8% | +$39.7K | ﹤0.01% | 2193 |
|
2015
Q3 | $471K | Buy |
88,869
+3,236
| +4% | +$17.2K | ﹤0.01% | 2265 |
|
2015
Q2 | $711K | Sell |
85,633
-10,605
| -11% | -$88.1K | ﹤0.01% | 2096 |
|
2015
Q1 | $445K | Buy |
96,238
+17,700
| +23% | +$81.8K | ﹤0.01% | 2362 |
|
2014
Q4 | $240K | Buy |
78,538
+2,275
| +3% | +$6.95K | ﹤0.01% | 2700 |
|
2014
Q3 | $212K | Buy |
76,263
+4,200
| +6% | +$11.7K | ﹤0.01% | 2718 |
|
2014
Q2 | $293K | Buy |
72,063
+4,504
| +7% | +$18.3K | ﹤0.01% | 2613 |
|
2014
Q1 | $359K | Sell |
67,559
-4,921
| -7% | -$26.2K | ﹤0.01% | 2422 |
|
2013
Q4 | $402K | Sell |
72,480
-710
| -1% | -$3.94K | ﹤0.01% | 2390 |
|
2013
Q3 | $330K | Sell |
73,190
-345
| -0.5% | -$1.56K | ﹤0.01% | 2468 |
|
2013
Q2 | $313K | Buy |
+73,535
| New | +$313K | ﹤0.01% | 2601 |
|